Irene Kaganman

To Start or not to Start?

Irene Kaganman, 2006, Nature Methods.

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.

Rebecca A Miksad, Sean Khozin, Amy P Abernethy, 2018, The oncologist.